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no such regional difference in type I collagen content in low-grade control
specimens (p=0.181).
Real-time PCR: COL2A1 expression was not signiﬁcantly different in regions
of damaged and preserved cartilage in AMG (p=0.156), low-grade control
(p=0.625) or high-grade control specimens (p=0.813). COL1A1 expression
in AMG specimens was signiﬁcantly greater in the preserved cartilage than
damaged cartilage (p=0.031). However, the regional difference in type I
collagen expression was not seen in low-grade (p=0.625) or high-grade
controls (p=0.219).
Conclusions: Type I collagen is abundant in ﬁbro-cartilage but only found
in very low levels in mature hyaline cartilage and is not usually found
in articular cartilage. Macroscopically normal cartilage in AMG exhibits
increased COL1A1 gene expression and a subsequent increase in type I
collagen matrix content. Type I collagen is also increased in the equivalent
region of knees with early histological features of OA
These ﬁndings suggest that these cartilage matrix and chondrocyte pheno-
type changes may be an early feature of OA change in AMG.
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A ROLE FOR TNF-LIKE WEAK INDUCER OF APOPTOSIS (TWEAK) DERIVED
FROM SYNOVIAL TISSUES AND CARTILAGE IN THE PATHOGENESIS OF
OSTEOARTHRITIS
D.R. Haynes1, K. Dharmapatni1, M.D. Smith2, D.Y. Chen1, C.A. Holding1,
H. Weedon2, A. Upton1
1Univ. of Adelaide, Adelaide, Australia; 2Repatriation Gen. Hosp., Adelaide,
Australia
Purpose: Previous studies have suggested that TWEAK may have an
important role in stimulating bone and cartilage destruction in various
arthritidies. The aim of this study was to investigate TWEAK and TWEAK
receptor (Fn14) expression in the cartilage and synovial tissues from os-
teoarthritic and normal (healthy) individuals. Protein expression of TWEAK
and TWEAK receptors (Fn14) was determined in cartilage from samples of
various grades of osteoarthritis (OA) and synovial tissue from patients with
OA and normal controls. TWEAK and Fn14 gene expression was studied in
various grades of OA cartilage. In addition, levels of soluble TWEAK present
in OA synovial ﬂuid were measured.
Methods: Synovial tissues from total of 10 OA and 10 normal subjects were
studied for TWEAK and Fn14 using immunohistochemistry. Osteoarthritic
cartilage was obtained from 21 patients undergoing primary hip replace-
ment and stained for TWEAK and Fn14 expression. Staining was assessed
using a standard semi-quantitative assessment carried out by two inde-
pendent observers. In addition, mRNA levels of TWEAK and Fn14 were
determined by real time RT PCR in the various grades of cartilage tissue.
TWEAK levels were measured in 15 OA synovial ﬂuid samples using a
commercial ELISA kit.
Results: Signiﬁcantly higher TWEAK (Figure 1A and B) and Fn14 was
detected in OA synovial tissue compared to the normal synovial tissue
(p<0.05) and expression was predominantly in the synovial lining.
In OA cartilage, the majority (18/21) all grades of samples expressed
TWEAK protein at low levels, whereas all samples (OA and normal) ex-
pressed high levels of Fn14 (Figure 1C and D). TWEAK and Fn14 mRNA was
more abundant in OA patients (Figure 2) with grade 2 cartilage damage
compared to those without any cartilage damage (p<0.05). TWEAK was
present in all OA synovial ﬂuids tested at a mean concentration of 713±134
pg/ml.
Figure 1. Synovial tissue expression of TWEAK (red stain) in OA and normal (B) tissues.
Cartilage tissue expression of Fn14 (red stain) in grade 2 (C) and grade 0 (D) tissues.
Conclusions: Previous studies have shown that TWEAK can induce met-
alloproteinase production in vitro by human chondrocytes and in murine
Figure 2. TWEAK and Fn14 mRNA in various grades of OA cartilage.
intervertebral disc tissues. As yet no studies have directly investigated the
presence of TWEAK and its receptor (FN14) in human OA tissues. The high
expression of Fn14 by chondrocytes in OA cartilage indicates that these
cells are able to respond to TWEAK. In OA tissues TWEAK was expressed
by chondrocytes in cartilage and highly expressed in the adjacent synovial
tissues. This is consistent with TWEAK protein in the OA synovial ﬂuid.
Overall the study indicates that TWEAK released from the synovial tissue
and chondrocytes in OA has a role in cartilage degradation.
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ELUCIDATION OF THE HUMAN CHONDROCYTE GLYCOME AND OF
ALTERING GLYCANS UNDER CYTOKINE TREATMENT
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1Dept. of Pharmaceutical Technology and Biopharmaceutics, Univ. of Vienna,
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Purpose: Recent evidence has indicated a relationship between osteoarthri-
tis and altered glycosylation of cartilage and chondrocytes. Although the
glycobiology of cells is known to affect adhesion, receptor activity or
apoptosis, little information exists on the N- or O-glycome of human chon-
drocytes and on their signiﬁcance for the functionality of cartilage tissue. In
part, this fact may result from the methodological challenges encountered
with low glycosyltransferase transcription levels and linkage-type speciﬁc
glycoprotein glycan analysis. This study aimed to elucidate the glycome
of cultured human chondrocytes using a combination of RT-qPCR and
structural glycan analysis (LC-ESI-MS) and to deﬁne alterations of cellular
glycans upon treatment of chondrocytes with pro-inﬂammatory cytokines.
Methods: Primary chondrocytes were isolated from human OA cartilage
(n=8). Primary cells, SW1353 and C-28/I2 chondrocytes were cultured
in DMEM with 10% FCS or 1% ITS. 10 ng/ml IL-1β or 40 ng/ml TNF-α
were added as a pro-inﬂammatory stimulus. SYBR green based RT-qPCR
assays for 19 glycosyltransferases and 5 galectins were established using
GAPDH as reference. N- and O-glycan isolation was performed by PNGase
(N-glycans) or sodium hydroxide (O-Glycan) digestion prior to structural
identiﬁcation by LC-ESI-MS using Porous Graphitized Carbon as stationary
phase.
Results: About 100 different N- and O-glycans were detected and quan-
tiﬁed in human chondrocytes in the presence or absence of FCS. Major
N-glycans were found as sialylated diantennary structures, oligomannosidic
or hybrid-type glycans. The isomers of diantennary and oligomannosidic
N-glycans were fully assigned. Some structures were sulfated, contained
GalNAc or Lewis fucose residues, whereas tri and tetraantennary glycans
were present only to a minor extent. O-glycosylation mainly constituted of
core-1 and core-2 structures bearing one or two α2,3 linked sialic acids.
Primary chondrocytes predominantly expressed α2,6-speciﬁc sialyltrans-
ferases (SiaT) and α2,6-linked sialic acid residues in glycoprotein N-glycans.
In contrast, the preponderance of α2,3-linked sialyl residues and reduced
levels of α2,6-speciﬁc SiaT were associated with the altered chondrocyte
phenotype of C-28/I2 and SW1353 cells. Importantly, we found that both
IL-1β and TNF-α increased overall sialylation of N- and O-glycans and
induced a shift towards α2,3-linked sialic acid residues in primary chon-
drocyte glycoproteins. These results were supported by RT-qPCR showing
increased expression of α2,3 SiaT in treated cells. Moreover, we found
that both cytokines induced a considerable shift from oligomannosidic
glycans towards complex-type N-glycans, whereas core α1,6-fucosylation
was found to be reduced particularly by TNF-α.
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Regarding galectin mRNA levels in human chondrocytes (n=8), we found
expression in the order: LGALS1 (0.36±0.13) > LGALS3 (0.18±0.06) >
LGALS8 (0.09±0.03) > LGALS9 (LGALS7 <0.00004).
Conclusions: Here, we have portrayed for the ﬁrst time the complete
glycome of human chondrocytes out of minute amounts of cultured cells
(100,000 cells). IL-1β and TNF-α induce a range of speciﬁc alterations in
chondrocyte glycoproteins supporting the hypothesis that the chondro-
cyte glycobiology might be of relevance for malfunctioning cell-matrix
interactions or altered galectin function under disease conditions.
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ROLE OF K(ATP) CHANNELS IN MODULATING GLUT-1 CONTENT IN
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Purpose: Our previous studies showed that human chondrocytes adjust
their glucose transport capacity and facilitative glucose transporter (GLUT)-
1 content in response to high and low extracellular glucose concentrations.
OA chondrocytes, however, fail to downregulate GLUT-1 content and glu-
cose transport when exposed to high extracellular glucose concentrations.
The consequent intracellular glucose accumulation causes prolonged oxida-
tive stress which can compromise chondrocyte functions. The mechanisms
by which chondrocytes sense the extracellular glucose concentration and
subsequently adjust GLUT-1 content are unknown. Functional ATP-sensitive
potassium [K(ATP)] channels were demonstrated in equine chondrocytes
and in other cells were shown to play an important role as metabolic
sensors. In pancreatic β cells, high extracellular glucose causes these chan-
nels to close, increasing the intracellular calcium concentration and insulin
secretion. Thus, we hypothesized that K(ATP) channels may function as
metabolic sensors in chondrocytes, generating the signals that lead to
adjustment of GLUT-1 content. To test this hypothesis, we evaluated the
ability of speciﬁc blockers (glibenclamide) and openers (levcromakalin) of
the K(ATP) channels to modulate GLUT-1 content in normal and OA human
chondrocytes.
Methods: Normal (N=5, 31-59 years old, mean=44) and OA (N=6, 60-72
years old, mean=65) human chondrocytes were obtained from multi-organ
donors or patients undergoing total knee replacement surgery, respectively,
at the University Hospitals of Combra. Non-proliferating chondrocyte cul-
tures were treated with glibenclamide or levcromakalin for 18h. GLUT-1
content and actin levels were evaluated in total cell extracts by western
blot.
Results: No signiﬁcant difference was found between basal GLUT-1 content
in normal and OA chondrocytes. Treatment of normal chondrocytes with
10, 20 and 100 nM glibenclamide signiﬁcantly decreased GLUT-1 con-
tent (61.8±10.1%, 57.9±11.3% and 61.2±7.9%, respectively) while 20 μM
(112±23.7%) had no effect, relatively to untreated cells. In the OA group,
however, none of the glibenclamide concentrations tested signiﬁcantly
affected GLUT-1 content. Treatment with 0.5 μM levcromakalin had no
signiﬁcant effect on GLUT-1 content either in normal (96±24.8%) or OA
(108±20.4%) chondrocytes.
Conclusions: These results suggest that closure of K(ATP) channels is
involved in GLUT-1 downregulation in human chondrocytes, consequently
modulating glucose transport. In OA chondrocytes, however, this process
seems to be impaired and thus may compromise their ability to adjust
glucose transport to metabolic needs.
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HUMAN OSTEOARTHRITIS CHONDROCYTES EXPRESS THE CALCITONIN
RECEPTOR
T. Segovia-Silvestre1, B.C. Sondergaard1, C. Bonnefond1, T. Christiansen2,
M.A. Karsdal1, A.-C. Bay-Jensen1
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Purpose: A growing body of evidence suggests that calcitonin (CT) has a
direct chondroprotective effect against degenerative joint disease in artic-
ular cartilage. The expression of the calcitonin receptor by chondrocytes is
currently a matter of debate. In this study, we sought to test the hypothesis
that human chondrocytes do express the calcitonin receptor.
Methods: We worked with fresh primary chondrocyte samples isolated
from arthroplasty cartilage specimens dissected from osteoarthritis pa-
tients. We established a dedicated reverse transcription polymerase chain
reaction (RT-PCR) protocol followed by a nested PCR assay aiming at
amplifying the full coding region of the calcitonin receptor mRNA (CALCR).
We optimized a western blotting protocol for characterizing calcitonin
receptor protein (CTR) immunoreactivity in chondrocyte samples using
human osteoclasts as positive controls. We validated an immunochemical
procedure for localizing CTR in both primary and in situ chondrocytes.
Results: We ampliﬁed and sequenced four different allelic variants of
CALCR in four patients. We detected a protein reacting against different
CTR antibodies in four other patients. The molecular weight of the chon-
drocyte protein corresponds to that expressed by human osteoclasts. The
plasma membrane of primary chondrocytes was intensely stained with one
of the CTR antibodies validated by western blotting.
Conclusions: Human articular cartilage chondrocytes express both the
mRNA and protein molecules of the calcitonin receptor. These ﬁndings sig-
nal the calcitonin receptor as a new pharmacological target in osteoarthritis
treatment.
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LEPTIN PRODUCED BY JOINT WHITE ADIPOSE TISSUE INDUCES
CARTILAGE DEGRADATION BY UP-REGULATION AND ACTIVATION OF
MATRIX METALLOPROTEINASES
H. Wang, T. Cawston, G. Litherland, G. Kitson, M. Elias, A.D. Rowan,
D.A. Young
Musculoskeletal Res. Group, Medical School, Newcastle upon Tyne, United
Kingdom
Purpose: investigate the effect of leptin on cartilage destruction in os-
teoarthritis.
Methods: The release of proteoglycan and collagen was assessed in bovine
cartilage explant cultures, while collagenolytic activities and gelatinolytic
activity in culture supernates were determined by bioassay and gelatin
zymography. The expression and production of MMPs was analyzed by
real-time reverse transcription polymerase chain reaction (RT-PCR). Sig-
nalling pathway activation was studied by immunoblotting. Levels of leptin
in the supernatants from cultured osteoarthritic (OA) joint infrapatellar fat
pad was measured by ELISA.
Results: Leptin signiﬁcantly induced collagen release from bovine cartilage,
by up-regulation of collagenolytic and genatinolytic activity. When added
in combination with IL-1, a marked synergistic and a dose-dependent
increased cartilage collagen release and enzyme activity was observed.
In cultured chondrocytes, leptin induced MMP-1 and MMP-13 expression
with a concomitant activation STATs -1, -3, -5, MAPK (JNK, Erk, p38), Akt
and NFκB pathways. Blockade of PI3K, P38, Erk and AKT pathway with
selective inhibitors signiﬁcantly reduced MMP-1 and MMP-13 expression
in chondrocytes, and reduced collagen release induced by leptin or leptin
+ IL-1 in bovine cartilage. Furthermore, we found that supernatants from
cultured OA joint infrapatellar fat pad contained leptin and can signiﬁcant
induce cartilage proteoglycan and collagen release from cartilage, and
increase MMP-1 and MMP-13 expression chondrocytes. An anti-leptin anti-
body was able to partially suppress the effects of the fat conditioned media
with respect to the induction of the collagenases by human chondrocytes.
Conclusions: This study demonstrates that leptin acts as a pro-
inﬂammatory cytokine with a catabolic role on cartilage metabolism
via the up-regulation and activation of proteolytic enzymes via PI3K, Akt,
Erk and STATs signalling pathways. Moreover, our data suggests that the
infrapatellar fat pad in arthritic joints is a local producer of leptin which
may contribute to inﬂammatory and degenerative processes in cartilage
metabolism, providing a mechanistic link between obesity and OA.
